NHLBI DIR LAMPOON Study

Eligibility Criteria

Inclusion Criteria

  • Undergoing TMVR for valve-in-ring, valve-in-band or valve-in MAC
  • Adults age ≥21 years
  • Severe symptomatic native mitral valve failure after mitral annuloplasty repair or related to mitral annular calcification
  • TMVR is felt indicated by the multi-disciplinary institutional heart team, including at least one cardiovascular surgeon who has examined the patient
  • High or prohibitive risk of LVOT obstruction (predicted neo-LVOT less than 200mm2)) or transcatheter heart valve dysfunction from long/redundant anterior mitral valve leaflet, as determined by the multidisciplinary institutional heart team
  • Anatomic eligibility for LAMPOON based on corelab assessment of the base-line CT and echocardiogram

Exclusion Criteria

  • Subjects unable to consent to participate, unless the subject has a legally authorized representative
  • Subjects unwilling to participate, or unwilling to return for study follow-up activities
  • Predicted neo-LVOT created by the Edwards SAPIEN 3 skirt, after LAMPOON, less than 150mm2
  • TAVR within 6 weeks
  • Intended concurrent structural heart procedure, such as aortic or tricuspid valve implantation
  • Pregnancy or intent to become pregnant prior to completion of all protocol follow-up procedures

Primary Investigator


undefined image

Jason Foerst, M.D.

Medical director of the Structural Heart and Valve Center at Carilion Clinic and an assistant professor of Medicine at the Virginia Tech Carilion School of Medicine.

Contact Information

Christina Bryant, R.N., R.C.I.S.

Clinical Research Nurse Coordinator